Correlation Between MaxCyte and Clearpoint Neuro

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MaxCyte and Clearpoint Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and Clearpoint Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MaxCyte and Clearpoint Neuro, you can compare the effects of market volatilities on MaxCyte and Clearpoint Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of Clearpoint Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and Clearpoint Neuro.

Diversification Opportunities for MaxCyte and Clearpoint Neuro

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between MaxCyte and Clearpoint is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and Clearpoint Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearpoint Neuro and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with Clearpoint Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearpoint Neuro has no effect on the direction of MaxCyte i.e., MaxCyte and Clearpoint Neuro go up and down completely randomly.

Pair Corralation between MaxCyte and Clearpoint Neuro

Given the investment horizon of 90 days MaxCyte is expected to under-perform the Clearpoint Neuro. But the stock apears to be less risky and, when comparing its historical volatility, MaxCyte is 1.26 times less risky than Clearpoint Neuro. The stock trades about -0.01 of its potential returns per unit of risk. The Clearpoint Neuro is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  721.00  in Clearpoint Neuro on September 2, 2024 and sell it today you would earn a total of  516.00  from holding Clearpoint Neuro or generate 71.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MaxCyte  vs.  Clearpoint Neuro

 Performance 
       Timeline  
MaxCyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Clearpoint Neuro 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clearpoint Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Clearpoint Neuro is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

MaxCyte and Clearpoint Neuro Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MaxCyte and Clearpoint Neuro

The main advantage of trading using opposite MaxCyte and Clearpoint Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, Clearpoint Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will offset losses from the drop in Clearpoint Neuro's long position.
The idea behind MaxCyte and Clearpoint Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals